BURE EQUITY AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323 SEK | -0.37% |
|
-1.34% | +13.02% |
| Feb. 22 | Bure Equity AB Proposes Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024 | CI |
| Feb. 22 | Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | -9.17B -840M | Sales 2023 | 4.81B 440M | Capitalization | 21.19B 1.94B |
|---|---|---|---|---|---|
| Net income 2022 | -9.24B -847M | Net income 2023 | 4.74B 435M | EV / Sales 2022 | -1.93 x |
| Net cash position 2022 | 529M 48.46M | Net cash position 2023 | 1.57B 144M | EV / Sales 2023 | 4.08 x |
| P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
4.47
x | Employees | 10 |
| Yield 2022 |
0.91% | Yield 2023 |
0.87% | Free-Float | 70.61% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.37% | ||
| 1 week | -1.34% | ||
| Current month | -5.78% | ||
| 1 month | -3.00% | ||
| 3 months | +15.11% | ||
| 6 months | +49.81% | ||
| Current year | +13.02% |
1 week
316.00
333.20
1 month
315.20346.00
Current year
272.40346.00
1 year
202.20346.00
3 years
171.30489.20
5 years
126.40489.20
10 years
26.40489.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 98-12-31 | |
Max Jonson
DFI | Director of Finance/CFO | 56 | 13-09-30 |
| Chairman | 60 | 98-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 19-04-30 | |
| Chairman | 60 | 98-12-31 | |
| Director/Board Member | 70 | 16-05-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 233 M€ | +6.49% | ||
| 0.01% | 773 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 323 | -0.37% | 28,773 |
| 24-04-18 | 324.2 | -0.43% | 31,654 |
| 24-04-17 | 325.6 | +0.99% | 24,616 |
| 24-04-16 | 322.4 | -2.13% | 33,785 |
| 24-04-15 | 329.4 | +0.61% | 31,497 |
Delayed Quote Nasdaq Stockholm, April 19, 2024 at 11:29 am EDT
More quotes
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Sector
Investment Holding Companies
Calendar
2024-05-06
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +13.02% | 2.2B | |
| +12.48% | 73.31B | |
| +55.08% | 16.73B | |
| +4.88% | 16.23B | |
| +7.45% | 14.17B | |
| -1.59% | 12.3B | |
| +10.19% | 12.1B | |
| +2.07% | 10.54B | |
| +26.90% | 9.95B | |
| -2.13% | 9.67B |
- Stock Market
- Equities
- BURE Stock
